Spinoff
![Sanofi’s ‘Play to Win’ strategy backfires, stock tumbles](https://pharmtales.com/wp-content/uploads/2023/10/Sanofis-‘Play-to-Win-strategy-backfires-stock-tumbles.jpg)
Sanofi’s ‘Play to Win’ strategy backfires, stock tumbles
Sanofi is facing investor discontent as its CEO, Paul Hudson, unveiled the latest chapter in the “Play to Win” strategy ...
![3M CEO talks healthcare spinoff, revenue drop | Pharma News](https://pharmtales.com/wp-content/uploads/2023/10/3M-CEO-updates-on-healthcare-spinoff-amid-revenue-decline.jpg)
3M CEO updates on healthcare spinoff amid revenue decline
In a recent company update, 3M has provided insights into the status of its long-anticipated healthcare business spinout, indicating that ...
![Sandoz's Subdued Market Entrance After Splitting from Novartis](https://pharmtales.com/wp-content/uploads/2023/10/Sandozs-Subdued-Market-Entrance-After-Splitting-from-Novartis.jpg)
Sandoz’s Subdued Market Entrance After Splitting from Novartis
Sandoz has successfully completed its separation from Novartis after extensive preparations lasting over a year. However, the initial valuation on ...
![Medtronic to sell its medical supplies unit to Carlyle Group for $7 billion](https://pharmtales.com/wp-content/uploads/2023/10/Medtronic-to-sell-its-medical-supplies-unit-to-Carlyle-Group-for-7-billion.jpg)
Medtronic to sell its medical supplies unit to Carlyle Group for $7 billion
In a significant development nearly a year after Medtronic’s announcement of its intention to spin off its patient monitoring and ...
![Novartis, Sandoz, spinoff, Generic drugs](https://pharmtales.com/wp-content/uploads/2023/08/Novartis-Nears-Sandoz-Spinoff-Milestone-with-Unique-Stock-Distribution-Strategy.jpg)
Novartis Nears Sandoz Spinoff Milestone with Unique Stock Distribution Strategy
As the long-anticipated spinoff of Novartis’ Sandoz division draws near, the Swiss pharmaceutical giant has unveiled a novel approach to ...
![AstraZeneca Sees China Sales Growth, Refutes Spinoff Report](https://pharmtales.com/wp-content/uploads/2023/07/AstraZeneca-Expects-Higher-China-Sales-Denies-Spinoff-Report.jpg)
AstraZeneca Expects Higher China Sales, Denies Spinoff Report
AstraZeneca’s CEO Pascal Soriot has denied a report that the company is considering spinning off its China business, which is ...